BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai YC, Wang WD, Zhang JA, Chen C, Luo HL, Xu H, Peng Y, Luo H, Yang XR, Chen X, Wu XJ, Chen GH, Chen ZW, Xu JF. MTB driven B cells producing IL-35 and secreting high level of IL-10 in the patients with active pulmonary tuberculosis. Mol Immunol 2019;112:175-81. [PMID: 31170628 DOI: 10.1016/j.molimm.2019.05.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Linge I, Kondratieva E, Apt A. Prolonged B-Lymphocyte-Mediated Immune and Inflammatory Responses to Tuberculosis Infection in the Lungs of TB-Resistant Mice. Int J Mol Sci 2023;24. [PMID: 36674664 DOI: 10.3390/ijms24021140] [Reference Citation Analysis]
2 Gupta T, Sarr D, Fantone K, Ashtiwi NM, Sakamoto K, Quinn FD, Rada B. Dual oxidase 1 is dispensable during Mycobacterium tuberculosis infection in mice. Front Immunol 2023;14:1044703. [PMID: 36936954 DOI: 10.3389/fimmu.2023.1044703] [Reference Citation Analysis]
3 Courey-ghaouzi A, Kleberg L, Sundling C. Alternative B Cell Differentiation During Infection and Inflammation. Front Immunol 2022;13:908034. [DOI: 10.3389/fimmu.2022.908034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang M, Li X, Wang Q, Zhang M, He J, Ming S, Wang Z, Cao C, Zhang S, Geng L, Gong S, Huang X, Chen K, Wu Y. TLT-1 Promotes Platelet–Monocyte Aggregate Formation to Induce IL-10–Producing B Cells in Tuberculosis. J I 2022;208:1642-1651. [DOI: 10.4049/jimmunol.2001218] [Reference Citation Analysis]
5 Yu F, Zhu X, Li Q, Xu W, Gao Y, Wen Y, Zhang Q, Dou J. Elevated IL-35 level and iTr35 subset increase the bacterial burden and lung lesions in Mycobacterium tuberculosis -infected mice. Open Life Sciences 2022;17:312-20. [DOI: 10.1515/biol-2022-0025] [Reference Citation Analysis]
6 Linge I, Tsareva A, Kondratieva E, Dyatlov A, Hidalgo J, Zvartsev R, Apt A. Pleiotropic Effect of IL-6 Produced by B-Lymphocytes During Early Phases of Adaptive Immune Responses Against TB Infection. Front Immunol 2022;13:750068. [PMID: 35154093 DOI: 10.3389/fimmu.2022.750068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jiang H, Cui B, Zhang J. Mycobacterium tuberculosis (MTB) antigen-induced upregulation of interleukin-35 expression in patients with MTB infection: In vitro blockade of the effects of interleukin-35 on T lymphocyte subsets. Pathog Dis 2021;79:ftab035. [PMID: 34245560 DOI: 10.1093/femspd/ftab035] [Reference Citation Analysis]
8 McGettigan SE, Debes GF. Immunoregulation by antibody secreting cells in inflammation, infection, and cancer. Immunol Rev 2021;303:103-18. [PMID: 34145601 DOI: 10.1111/imr.12991] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wen Q, Li Y, Han Z, Liu H, Zhang S, Chen Y, He J, Du X, Fu Y, Zhang L, Zhang Z, Huang Y, Zhou X, Zhou C, Hu S, Ma L. β-Arrestin 2 Regulates Inflammatory Responses against Mycobacterium tuberculosis Infection through ERK1/2 Signaling. J Immunol 2021;206:2623-37. [PMID: 34001657 DOI: 10.4049/jimmunol.2001346] [Reference Citation Analysis]
10 Catalán D, Mansilla MA, Ferrier A, Soto L, Oleinika K, Aguillón JC, Aravena O. Immunosuppressive Mechanisms of Regulatory B Cells. Front Immunol 2021;12:611795. [PMID: 33995344 DOI: 10.3389/fimmu.2021.611795] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 20.5] [Reference Citation Analysis]
11 Sun YF, Pi J, Xu JF. Emerging Role of Exosomes in Tuberculosis: From Immunity Regulations to Vaccine and Immunotherapy. Front Immunol 2021;12:628973. [PMID: 33868247 DOI: 10.3389/fimmu.2021.628973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ali ZA, Mankhi AA, Ad'hiah AH. Significance of the chemokine CXCL10 and human beta-defensin-3 as biomarkers of pulmonary tuberculosis. Tuberculosis (Edinb) 2021;128:102078. [PMID: 33773403 DOI: 10.1016/j.tube.2021.102078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Davis A, Guldberg RE, Samsonraj RM. OSTEOIMMUNOLOGICAL IMPLICATIONS IN REGENERATIVE MEDICINE: CROSS-TALK BETWEEN MESENCHYMAL STEM CELLS AND IMMUNE CELLS. J Musculoskelet Res 2021;24:2140001. [DOI: 10.1142/s0218957721400017] [Reference Citation Analysis]
14 Liu J, Chen X, Wang J, Wu F, Zhang J, Dong J, Zhang H, Liu X, Hu N, Wu J, Zhang L, Cheng W, Zhang C, Zhang WJ. Prediction and identification of CD4+ T cell epitope for the protective antigens of Mycobacterium tuberculosis. Medicine (Baltimore) 2021;100:e24619. [PMID: 33578573 DOI: 10.1097/MD.0000000000024619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Chen C, Xu H, Peng Y, Luo H, Huang GX, Wu XJ, Dai YC, Luo HL, Zhang JA, Zheng BY, Zhang XN, Chen ZW, Xu JF. Elevation in the counts of IL-35-producing B cells infiltrating into lung tissue in mycobacterial infection is associated with the downregulation of Th1/Th17 and upregulation of Foxp3+Treg. Sci Rep 2020;10:13212. [PMID: 32764544 DOI: 10.1038/s41598-020-69984-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
16 Kelly AM, McLoughlin RM. Target the Host, Kill the Bug; Targeting Host Respiratory Immunosuppressive Responses as a Novel Strategy to Improve Bacterial Clearance During Lung Infection. Front Immunol 2020;11:767. [PMID: 32425944 DOI: 10.3389/fimmu.2020.00767] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Dasgupta S, Dasgupta S, Bandyopadhyay M. Regulatory B cells in infection, inflammation, and autoimmunity. Cell Immunol 2020;352:104076. [PMID: 32143836 DOI: 10.1016/j.cellimm.2020.104076] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 10.3] [Reference Citation Analysis]